Korean J Dermatol.
2004 Jun;42(6):675-681.
The Relapse Rate after 1 Year Treatment with Oral Isotretinoin in Korean Patients with Mild to Moderate Acne
- Affiliations
-
- 1Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Korea. choieh@wonju.yonsei.ac.kr
- 2Department of Preventive Medicine and Institute of Occupational Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
- 3Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.
- 4Department of Dermatology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
- 5Department of Dermatology, Yonsei University College of Medicine, Seoul, Korea.
Abstract
- BACKGROUND
The efficacy of isotretinoin in the treatment of acne has been widely established. Recently oral isotretinoin has been used for any grades and any types of acne. There have been many articles on long-term follow up data with oral isotretinoin therapy. OBJECTIVE: To assess, after 1 year post-treatment with oral isotretinoin, the relapse rate, risk factor which influence the outcome, and the total cumulative dose of oral isotretinoin in mild to moderate acne patients in Korea, prospectively. MATERIAL AND METHODS: Patients with mild to moderate acne, visiting out-patient dermatology clinics of four university hospitals have taken oral isotretinoin 0.3-1.0mg/kg/day over 16 weeks. The outcomes were evaluated by telephone contact, with regard to relapse, further treatment in cases of relapse; subjective assessment of sebum secretion and patient satisfaction. A total of 230 patients were evaluated at the end of the preliminary report, and 124 out of the 230 were contacted in this 1 year follow up. RESULT: A relapse rate of 25% was obtained on our study. The patient's sex, seborrhea, acne grade prior to treatment, previous severest acne grade did not influence the relapse rate. It appeared that young age and the total cumulative dose (TCD) influenced the percentage of relapse. About 71.3% of patients were satisfied with the result after 1 year post-treatment with oral isotretinoin. CONCLUSION: The dose schedule, in particular the cumulative dose, was an important factor in determining the relapse rate. It is capable of producing a low relapse rate and long-term remission in mild to moderate acne patients in Korea, if given in a dose regimen of a cumulative dose of 80 mg/kg.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Efficacy and Safety of Isotretinoin in Korean Patients with Mild to Moderate Acne
- Recurrence of Acne after Oral Isotretinoin
- The Effect of Oral Isotretinoin on the Barrier Function of the Lipsof Acne Patients and the Protective Role of Moisturizer
- A Case of Acne Fulminans Treated with Oral Isotretinoin and Systemic Corticosteroid
- A Case of Acne Fulminans after Oral Isotretinoin Therapy
